Search - tctmd.com

Displaying 141 - 160 of 205

Sort: Relevancy | Date

News Daily News

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Yael L. Maxwell

December 13, 2015

News Daily News

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

Michael O'Riordan

December 13, 2015

News Daily News

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Michael O'Riordan

December 08, 2015

News Industry News

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality

November 17, 2015

News Daily News

混合成像方法具有针对易损冠状动脉斑块的高鉴别力

L.A. McKeown

October 13, 2015

News Daily News

Hybrid Imaging Approach Offers High Discriminatory Ability for Vulnerable Coronary Plaques

L.A. McKeown

October 13, 2015

News Daily News

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

L.A. McKeown

October 13, 2015

News Industry News

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

October 12, 2015

Presentation

Direct Comparison of VH-IVUS and OCT Imaging for Identification of Thin-Cap Fibroatheroma

Presenter: AJ. Brown

October 09, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

Presentation Aortovascular 2015

Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies

Presenter: William A. Gray

September 18, 2015

News Industry News

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

September 11, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

新型反义抑制剂能够降低高甘油三酯水平

August 13, 2015

News Daily News

Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos

August 13, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Industry News

Lilly Provides Update on Evacetrapib Phase 3 Trial

July 27, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

Advertisement

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

New Publication Featuring GlycoMark® Test Highlights Association of Hyperglycemic Excursions With Cardiovascular Outcomes And Mortality

混合成像方法具有针对易损冠状动脉斑块的高鉴别力

Hybrid Imaging Approach Offers High Discriminatory Ability for Vulnerable Coronary Plaques

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

Lilly to Discontinue Development of Evacetrapib for High-Risk Atherosclerotic Cardiovascular Disease

Direct Comparison of VH-IVUS and OCT Imaging for Identification of Thin-Cap Fibroatheroma

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

Scaffolds, Injectables, Tacks, Smashers, etc: Future endovascular therapies

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

新型反义抑制剂能够降低高甘油三酯水平

Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos

Novel Antisense Inhibitor Cuts High Triglyceride Levels

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

Lilly Provides Update on Evacetrapib Phase 3 Trial

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content